Peptris

Peptris Technologies is an AI-powered preclinical drug discovery company that uses proprietary machine learning and generative AI to design optimized molecules across oncology, inflammation, and rare disease indications. Its platform integrates unsupervised learning with large language models trained on molecular syntax to rapidly screen virtual chemical libraries and generate novel, patentable drug candidates. Peptris operates a virtual model, outsourcing wet lab work to CROs while monetizing through licensing deals, milestone payments, and royalties.